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ABSTRACT 
Integrin conformational changes mediate integrin activation and signaling triggered by 
intracellular molecules or extracellular ligands. Even though it has been shown that TM and/or 
cytoplasmic  and  domains associate in the resting state and separation of these domains is 
required for integrin signaling, it is still not clear how this signal is transmitted from the 
transmembrane domain through two long extracellular legs to the ligand-binding headpiece. In 
addition, integrin TM homomeric association was also observed. But the role of this interaction 
remains elusive. In this work, the platelet integrin, IIb3, has been used to elucidate the roles of 
integrin lower leg and TM homomeric association in integrin signalling.   
We first addressed whether the separation of integrin αβ lower leg is critical for integrin 
activation and outside-in signaling. Using a disulfide bond to restrict dissociation of the α-
subunit Calf-2 domain and β-subunit I-EGF4 domain, we were able to abolish integrin inside-out 
activation and outside-in signaling. In contrast, disrupting the interface by introducing a 
glycosylation site into either subunit activated integrins for ligand binding through a global 
conformational change.  Our results suggest that the interface of the α-subunit Calf-2 domain and 
β-subunit I-EGF4 domain is critical for integrin bidirectional signaling.  
Formation of the TM homooligomers was observed in micelles and bacterial membranes 
previously, and it has been proposed that this homomeric association is important for integrin 
activation and clustering. We then addressed whether integrin TM domains form homooligomers 
in mammalian cell membranes using cysteine mutagenesis scanning method. Our results show 
that TM homomeric interaction does not occur before or after soluble ligand binding, or during 
inside-out activation. In addition, even though the cysteine mutants and the heterodimeric 
disulfide-bounded mutant could form clusters after adhering to immobilized ligand, the integrin 
TM domains do not form homooligomers, suggesting that integrin TM homomeric association is 
vii 
not critical for integrin clustering or outside-in signaling. Therefore, the integrin TM 
homooligomerization is not required for integrin activation, ligand binding and signaling. 
 
1 
CHAPTER ONE:  
GENERAL INTRODUCTION 
2 
Introduction 
Integrins are a large family of cell adhesion receptors that mediate cell-cell, cell-
extracellular matrix (ECM), and cell-pathogen interactions. These receptors are principal 
transmembrane proteins in that they connect the ECM with the actin cytoskeleton and a variety 
of signalling molecules. As they integrate the extracellular and intracellular environments by 
transmitting signals bidirectionally across the plasma membrane [1, 2], they were given the name 
“integrin”. Cooperated with other proteins, integrins play critical roles in many biological 
processes including hemostasis, inflammation, immune responses, development and cancer. 
Integrins are usually in low affinity state under physiological conditions. When cells are 
stimulated by external agents, specific intracellular molecules impinge on integrin cytoplasmic 
domains, resulting in its conformational change and thus leading to increase of affinity for 
extracellular ligands. This process is called inside-out signaling, which is the unique feature of 
integrin receptors compared to other adhesion receptors. On the other hand, ligand binding 
transduces signals from the extracellular environment to the cytoplasm and activates many 
intracellular signaling pathways, a process known as outside-in signaling.  
Integrins are expressed in all animals investigated and are of critical importance to them. 
In vertebrates, 18 -subunits and 8 -subunits have been identified, forming at least 24 distinct 
 pairs (Fig. 1.1). Each of the 24 integrins has a specific, nonredundant function [3]. In this 
study, we investigated the bidirectional signalling of the most intensively studied integrin 
IIb3.  
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Figure 1.1 The mammalian integrin receptor family. 18  and 8  subunits form 24 heterodimers.  
subunits with gray hatching or stippling have inserted domain. The figure is adapted from the review 
[3]. 
 
Biology of IIb3 
             IIb3, also known as glycoprotein IIb/IIIa, is expressed on the surface of platelets and 
their precursor megakaryotes [4]. The formation of the IIb3 complex from both IIb and 3 
subunits is necessary for the receptor to be expressed on the cell surface [5]. The assembly 
occurs in the endoplasmic reticulum (ER), and then the complex is transported to the Golgi for 
post-translational processing [6, 7]. Mature IIb contains 1008 amino acids and 3 has 762 
amino acids [8 ]. As the main platelet integrin, IIb3 mediates platelet aggregation and thus is 
essential for thrombosis and hemostasis. In unstimulated platelets, IIb3 is in the inactive, low 
affinity state. The activation of the receptor occurs through inside-out signalling, in which the 
platelets are stimulated by external agonists such as adenosine diphosphate (ADP), thrombin and 
thromboxane A2, resulting in conformational change and thus facilitating the major ligand 
fibrinogen binding. Platelets are therefore cross-linked through fibrinogen, causing platelet 
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aggregation. There are approximately 80,000 IIb3 copies on the membrane of each platelet 
[9]. Dysfunction or shortage of IIb3 can result in the bleeding disorder Glanzmann 
thrombasthenia [7]. The antagonists to IIb3 such as abciximab, eptifibatide and tirofiban were 
prescribed for the prevention of thrombosis. But the therapy of  Glanzmann thrombasthenia 
remains unsatisfactory due to the fact that binding to platelets by these drugs can cause 
conformational changes of IIb3, resulting in paradoxical thrombosis [7]. Investigation of the 
structure and function of IIb3 will lead to additional and improved ways to prevent or treat the 
pathological consequences of IIb3 dysfunction.  
IIb3 Structure 
Domain Organization and Overall Structure 
           Integrins are heterodimeric glycoproteins composed of two distinct noncovalently 
associated  and  subunits, each with a large extracellular domain, a single spanning 
transmembrane (TM) domain and a short cytoplasmic domain. Two groups of integrins have 
been identified: one containing an extra von Willebrand factor type A domain (domain) in 
their subunits; whereas the other including IIb3 lacking this domain (Fig. 1.1). As a typical 
lacking integrin, IIb subunit extracellular portion consists of four domains: an N-terminal 
seven-bladed –propeller domain and three –sandwich domains: the thigh, calf-1 and calf-2 
domains. The 3 extracellular portion contains eight domains: an N-terminal domain, a 
hybrid domain, a cysteine-rich PSI (Plexin-Semaphorin-Integrin) domain, four epidermal growth 
factor-like (EGF-like) domains and a membrane proximal tail domain (TD) (Fig. 1.2). The –
propeller domain from the subunit and the I domain from the subunit assemble to form a 
“headpiece”. Two “legs” are formed by the remaining extracellular domains of the two subunits 
(Fig. 1.2b). Initially, IIb3 structure obtained by electron microscopy (EM) revealed a large 
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globular head domain of approximately 80 Å diameter followed by a long rigid stalk comprising 
two flexible tails approximately 170 Å in length [10, 11]. Later on, X-ray crystal structures of the 
extracellular domains of the integrin V3 and IIb3 revealed that the legs were severely bent 
at the “genu” or knee (located between the Hybrid and Calf-1 domains in the , and between 
EGF1 and EGF2 in the ), generating a V-shaped topology in which the head domain was 
closely juxtaposed to the membrane-proximal portions of the stalks [12, 13] (Fig. 1.3, 1.5①). 
Mutational and EM studies of different integrins established that the bent conformation 
represents the physiological resting state [14, 15].  
 
 
Figure 1.2 Integrin architecture. (a) Organization of domains within the primary structures. Some  
subunits contain an I domain inserted in the position denoted by the dotted lines. Cysteines and disulfides 
are shown as lines below the stick figures. (b) Schematic of the course of the andsubunit polypeptide 
chains through domains from the N to C termini.  The figures are adapted from the review [16]. 
 
The -subunit Extracellular Domains  
                The N-terminal -propeller domain is formed by seven-fold ~60 amino acid repeats 
arranged like blades of a propeller. Each repeat or blade contains a four-stranded  sheet. The 
seven-bladed -propeller was initially predicted by computational methods [17] and later 
confirmed by crystal structures [12, 13, 18, 19]. The -propeller forms the the  subunit head 
domain and provides a critical interface with the -subunit (Fig. 1.3). On the bottom face of -
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propeller, four Ca
2+
 ions are chelated by loops in blades 4-7 [13]. Interestingly, the crystal 
structure of IIb3 headpiece reveals a cap sub-domain that comprises four insertions in the -
propeller. Although probably not involved in allosteric regulation, the cap contributes 
functionally to ligand binding as demonstrated by mutagenesis studies [20]. The marked 
variation in the length and sequence of the inserts among  subunits suggests a role of the cap in 
determining ligand binding specificity [19]. 
 
Figure 1.3 Crystal structure of integrin b3. (A) Structure of the b3 in the bent conformation. 
(B) An extended model of b3 by torsion at the and  knees. (From PDB ID code 3FCS.) 
 
The thigh, calf-1 and calf-2 domains, which constitute the remaining portion of the -
subunit extracellular domains, are three immunoglobulin-like-sandwich domains orderly 
arranged after the -propeller domain and comprise the leg of the -subunit, with the thigh 
domain in the upper leg and calf-1 and calf-2 domains in the lower leg (Fig.1.2b, 1.3). These 
three domains have similar folds and are longer than typical Ig-like domains. A small Ca
2+
-
binding loop located between the thigh and calf-1 domains represents the -subunit genu (Fig. 
1.3). 
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The -subunit Extracellular Domains 
The -subunit organization is more complicated than that of the -subunit. The  I 
domain is a highly conserved domain with ~240 residues and adopts a Rossmann fold, in which 
-helices and -strands alternate in the secondary structure and a central -sheet is surrounded 
by -helices in the tertiary structure. Additionally, the  I domain contains two additional 
segments: one forms the interface with -propeller and the other is known as the specificity-
determining loop because of its role in ligand binding. The interacting interface between  I 
domain and -propeller is much greater than any other domain-domain interface in integrins. In 
addition, the  I domain contains three metal ion-binding sites: the metal ion dependent adhesion 
site (MIDAS); SyMBS (synergistic metal ion binding site) and ADMIDAS (adjacent to 
MIDAS), which shares some coordinating residues with the MIDAS. The  I domain MIDAS 
appears to directly bind the ligand.  
The  I domain is inserted in the-sandwich hybrid domain, which is in turn inserted in 
the PSI domain (Fig. 1.2a). The hybrid domain makes extensive contact with the  I domain. Its 
structure resembles the I-set Ig domains [21]. The PSI domain consists of a two-stranded 
antiparallel  sheet flanked by two short helices [22]. The inserted topology of the  I domain 
plays a critical role in its allosteric regulation and signaling, as discussed below. 
PSI domain connects the hybrid domain with the lower leg of β-subunit, which contains 
four I-EGF domains and a β-tail domain (Fig. 1.2b). The Vβ3 crystal structure revealed that I-
EGF3-4 domains assume the structure of a classic I-EGF fold and contain rich disulfide bonds 
typical for EGF domains [12]. Recently, crystal structure of the entire extracellular domain of 
IIbβ3 in a physiologically resting state has been solved [13] (Fig. 1.3). In this structure, there is 
a highly acute bend between the I-EGF domains 1 and 2 (the β “knee”). In contrast, I-EGF 
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domains 2, 3 and 4 extend in an almost straight orientation. I-EGF4 domain is followed by β-tail 
domain, which consists of a four-stranded β sheet and contacts with β I domain in the Vβ3 
crystal structure but not in the IIbβ3 crystal structure [12, 13].  
Transmembrane and Cytoplasmic Domains 
          In contrast to the crystal structures of integrin extracellular domains, the structural studies 
of transmembrane and/or cytoplasmic domains produce conflicting results, in which the  and  
transmembrane and/or cytoplasimc fragments are either dissociated or associated with different 
interfaces [23, 24-32]. Although early work failed to detect the association of the  and  
transmembrane and/or cytoplasimc domains [23, 24], later studies, which demonstrated the 
interactions of the  and  subunits in this region [25-32], have been widely accepted. Despite 
the fact that residues associate differently in various data, the GXXXG motif from the 
transmembrane domains and GFFKR motif from the cytoplasmic domains were generally 
considered to contribute to the association. Last year, a newly developed method combining 
disulfide scanning with Rosetta computational modeling has been used to solve the structure of 
IIbβ3 TM and cytoplasmic domains [30]. Since the structure is obtained based on experimental 
data using intact integrins with the extracellular and cytoplasmic domains that regulate TM 
association on the mammalian cell surface, we believe that it most likely represents the 
physiological structure in the resting state. In this structure, the IIb GXXXG motif and their 3 
counterparts of the TM domains associate with a ridge-in-groove packing (Fig. 1.4A). The IIb 
TM -helix extends beyond the 23-residue TM hydrophobic segment and then Gly-991 of 
GFFKR is a turn which changes the TM right-handed -helix to a left-handed one, making Phe-
992 and Phe-993 sit in the interface of IIb and β3 at the membrane/cytoplasm interface (Fig. 
1.4B), and thus, this motif is critical for /β association. A salt bridge between IIb Arg-995 and 
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3 Asp-723 was proposed previously based on mutagenesis data [33]. In the structure, Arg-995 
is close to both Asp-723 and Glu-726, consistent with this electrostatic interaction. However, 
there are a variety of different conformations of the side chains of Arg-995 and Asp-723, 
indicating that this salt bridge is not absolutely necessary for the association.  
 
Figure 1.4  Structure of the integrin IIb3 transmembrane (TM) and cytoplasmic domains.  
(A) The interface between two associating TM domains on the cell surface.  
(B) Cytoplasmic fragment association of integrin IIb  and 3 subunits in the Disulfide/Rosetta structure. 
The figures are adapted from [30]. 
 
IIb3 Activation 
         The activation of IIb3 is tightly regulated through inside-out signalling. As described 
above, upon stimulation of external agents, IIb3 undergoes conformational rearrangement and 
facilitates ligand binding. Understanding the conformational changes of the overall structure and 
individual domains of IIb3 is crucial to unravel the mechanism of its signalling transduction 
and to successfully design a target drug. Two different models of IIb3 activation, the 
switchblade model and the deadbolt model, have been proposed to interpret the overall 
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conformational rearrangement of integrins [15, 19, 34].  I will describe the first model in detail, 
and discuss the second one later. 
The Switchblade Model 
            The “switchblade” model proposes that the bent conformation represents the 
physiological resting state, and upon activation integrins undergo a large global conformational 
change that results in a fully extended conformation and a switchblade-like hybrid domain 
swing-out [15, 19], leading to the conformational change at the ligand binding headpiece, 
especially the  I domain, therefore increasing affinity for ligands (Fig. 1.5). This marked change 
in tertiary structure is supported by X-ray crystallography [19], electron microscopy (EM) [14, 
15, 35, 36], solution X-ray scattering [37], antibody epitope mapping [38], and mutational 
studies [15, 16, 37, 39-44]. 
 
 
Figure 1.5 The switchblade model. Domain rearrangement of integrins during activation. The  subunit 
lower legs are flexible and are therefore shown in what may be the predominant (solid representation) and 
less predominant (dashed lines) orientations. The figures are adapted from the review [16]. 
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Conformational Change of  I Domain 
The structure of the  I domain was first solved in the context of V3 extracellular 
domains in the absence of ligand [12]. Subsequent mutagenesis studies [41-43, 45, 46] and the 
structure of the IIb3 headpiece co-crystallized with different ligand mimetic drugs [19] 
revealed conformational change in the open, high affinity state of the  I domain. With the 
higher resolution (2.55Å) of IIb3 complete ectodomain crystal structure [13], more detailed 
conformational changes in the  I domain can be obtained by superimposition of the headpieces 
from this physiologically resting, unliganded, closed structure with the high-affinity, liganded, 
open structure (Fig. 1.6). The inward movement of the 1-1 loop and the 1 helix is tightly 
coupled with the downward displacement of the 6-7 loop and the 7 helix from the resting 
state to the active state. This linkage is critical for propagation of conformational signals from 
the ligand binding pocket to the other integrin domains and vice versa. The coordination of the 
Met335 backbone carbonyl in the 6-7 loop to the ADMIDAS metal ion (Ca2+ in physiologic 
condition) in the low-affinity conformation is broken in the high-affinity conformation. The 
breaking of this coordination in turn enables the inward movements of 1-1 loop and the 
ADMIDAS Ca
2+
 toward the MIDAS metal ion (Mg
2+
 in physiologic condition) (Fig. 1.6), which 
is the major difference between the high and low-affinity conformations of the  I domain ligand 
binding site, consistent with earlier findings [18, 19].  
The Swing-out of the Hybrid Domains 
Since the  I domain is inserted into the hybrid domain and they have extensive contact 
to each other, the activation and movement of the  I domains will inevitably cause 
conformational changes of the hybrid domain. As a consequence of the inserted topology of the 
 I domain into the hybrid domain, the downward displacement of the 7-helix in the high-
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affinity, liganded crystal structure results in complete remodeling of the interface between these 
domains, leading to the swing-out of the hybrid domain [19] (Fig. 1.6). Compared to the closed 
conformation, the hybrid domain swings out about 60°, resulting in the separation of the knees of 
the  and  subunits by 70 Å (Fig. 1.6). The two conformations of the integrin headpiece were 
supported by EM studies of integrin V3 [15] and 51 [35, 47] and a range of other studies 
[40, 42, 47-49]. 
 
 
Figure 1.6 Conformational change and allosteric transmission by  I domains. Superposition of 
closed and open structures of the  I domains and their linkages to hybrid and PSI domains. (From PDB 
ID codes 3FCS and 2VDL). Nonmoving segments of backbone are shown as a gray worm. The moving 
segments of the backbone and the MIDAS metal ions are cyan (closed) and red (open). The direction of 
movement is indicated with arrows.  
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Separation of the Lower Legs 
Crystal [12, 13, 18] and EM [15] structures provide direct evidence that in the resting 
state the membrane-proximal portion of the extracellular domains of the  and  subunits are in 
close juxtaposition. Enforced association of the two stalks with acid/base coiled coils renders 
integrin low affinity, whereas release of these constraints promotes high affinity ligand binding 
[50]. Introducing a 10-residue flexible spacer between the extracellular domain and the TM 
domain enhanced M2 ligand binding on the cell surface [51]. Crystal structure of the open 
IIb3 headpiece [19] and EM structure of the entire V3 extracellular domains [15] 
confirmed that the two stalks separate during integrin activation or ligand binding. The lower  
leg in the averaged EM images of the open conformation tended to disappear, suggesting that the 
 lower leg is highly flexible and varied in conformations among individual particles [15]. 
Therefore, even though the crystal structure of the open IIb3 headpiece indicated that the 
swing-out of the hybrid domain results in a 70 Å separation at the knees [19], the distance 
between the two C-terminal stalks in the open conformations may vary, and this variation will 
result in a spectrum of different conformations. The stalk separation is a key step for integrins to 
transmit signals bidirectionally across the plasma membrane. 
The Models of TM and Cytoplasmic Domain Activation 
The TM and cytoplasmic domains are key for integrin inside-out and outside-in 
signaling, since both signals must be conveyed across the plasma membrane. Several models 
have been proposed to interpret how signals are transmitted across the cell membrane. These 
models are distinguished by the positional changes of the TM domains in the lipid bilayer. In the 
„piston‟ model, either the  subunit, the  subunit, or both subunits move vertically in the 
membrane for integrin activation [52]. The „twist‟ and „scissor‟ models propose that a fulcrum, 
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formed by association of the  and  subunits within or nearby cell membrane, must occur for 
signal transduction, based upon which the  and  TM domains are either „twisted‟ or 
undergoing a scissor-like movement [52, 53]. Recently, the separation of TM and cytoplasmic 
domains has become widely accepted, which is discussed as follows.  
Many studies showed that deletions or mutations in the  and  subunit TM and 
cytoplasmic domains, which are expected to destabilize / association, activate integrins [33, 
54-57]. FRET study shows that in the resting state the integrin  and  subunit cytoplasmic 
domains are close to one another, but undergo significant spatial separation upon inside-out 
activation induced by phorbol ester or talin head domain or outside-in signaling induced by 
ligand binding [58]. NMR studies of the integrin cytoplasmic tails suggest that their association 
is weak, with significant differences observed between published structures [25-27], or that 
association is undetectable [24]. These studies imply that the cytoplasmic interaction is modest 
and/or transient. Binding of intracellular proteins such as RAPL [59] or the talin head domain 
[60-62] to the integrin cytoplasmic tails induces tail separation and activate integrins for ligand 
binding [25]. The structural basis for binding of talin head domain and filamin to the integrin  
cytoplasmic domain resulting in integrin activation has been demonstrated by NMR studies [61-
64]. The separation rather than rearrangement of TM domains was further supported by 
mutagenesis studies, in which introduction of disulfide bridges to prevent or reverse separation 
abolished the activating effect of cytoplasmic mutations [28], whereas mutations that disrupt the 
TM interface activate integrins [29, 65, 66].   
         The tilting of the 3 helix within the membrane may provide another possible mechanism 
for integrin activation. The comparisons of the Disulfide/Rosetta structure [30] with the NMR 
structures of isolated IIb and 3 TM/cytoplasmic domain fragments [67, 68], which are 
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believed to represent the physiologically active state, gave some clues about the mechanism [69] 
(Fig. 1.7). The isolated IIb and 3 TM/cytoplasmic NMR structures are similar with the 
Disulfide/Rosetta structure. The dissociated 3 TM domain solved by NMR appeared to be a 30-
residue linear -helix extended into the cytoplasm, and instead of the 23 TM residues in the 
Disulfide/Rosetta complex structure, 29 residues appeared to be embedded in the bicelle core. In 
the NMR structure, 3 Lys-716 is followed by a 5-residue hydrophobic segment (L717LITI721), 
and the continuous helix spanning the TM and juxtamembrane segments could undergo a 
substantial tilt in the membrane, with snorkeling of the Lys-716 side chains into the polar 
environment [67]. By contrast, the 3 helix embedded in lipid membrane in the 
Disulfide/Rosetta complex structure is significantly shorter, suggesting that after dissociating 
from the IIb helix, the 3 helix is tilted with an angle of 20-30° due to inserting of 5-6 
additional hydrophobic residues to the hydrophobic lipid environment. The tilting of the 3 helix 
can be caused by force transmission from the actin cytoskeleton since the integrins are activated 
by force applied to the actin cytoskeleton that binds to the  cytoplasmic domain [13]. This 
tilting of the 3 helix may be important for integrin activation and signaling.      
             Interestingly, the structure of integrin IIb3 TM and cytoplasmic domain complex was 
also solved by NMR in the presence of phospholipid bicelles, and it was found to have a similar 
interhelical interface to the Disulfide/Rosetta structure [31]. However, the NMR structure was 
solved using an artificial hydrogen-bond constraint between the IIb(R995)- 3(D723). The 
presence of the salt bridge was based on the fact that mutations of either residue affected the 
helix-helix interaction as monitored by NMR. We propose that this electrostatic interaction is 
important for the priming of helix-helix interaction. After forming more stable helix-helix 
interaction, the salt bridge is probably not critical for further stabilization. Therefore, the NMR 
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structure might represent an “intermediate” or “transient” state between the physiological resting 
state (represented as the Disulfide/Rosetta structure) and the dissociated active state (represented 
as the NMR structure of the isolated monomers as discussed below) (Fig. 1.7). It is interesting 
that the NMR structures of the complex have almost identical structures and angles within the 
membrane to the isolated monomers, and there were substantial amounts of IIb and 3 
monomers present in the solution used for determining the NMR complex structures. These 
observations confirm our hypothesis that the NMR structure of the complex is an intermediate or 
“transient” state. 
 
Figure 1.7 Predicted model of integrin TM activation. (I) The resting state represented as 
Disulfide/Rosetta structure; (II) the “intermediate” or “transient” state represented as NMR structure of 
integrin IIb3 TM and cytoplasmic domain peptides (PDB ID 2K9J); (III) the activated state 
represented as monomeric IIb and 3 NMR structures (PDB ID codes 2K1A and 2RMZ).  The charges 
shown in II and III are proposed to be important for the initial association of  and  subunits. The outer 
bounds of the hydrophobic, interface, and polar region of the membrane are shown as black, red, and 
green lines, respectively. 
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 Homooligomerization of TM Domains 
         Although the heterodimeric association of / TM domains in the resting state has been 
widely accepted, the homomeric association of isolated integrin TM fragments was also 
proposed [23, 70, 71, 72]. In 2001, Li et al. failed to detect the heterodimeric association between 
TM  and  fragments in micelles using various methods including ultracentrifugation and NMR 
study. Instead, they observed the  homodimers and  homotrimers [23]. Later, αIIb and β3 TM 
helices were confirmed to form homooligomers in bacterial membranes using TOXCAT assay, 
with the similar interfaces as in heterodimers [70, 72]. Asparagine mutagenesis in this region of 
β3 subunit indicated that M701N and G708N can activate integrin for ligand binding. 
Furthermore, G708N was believed to induce β TM homotrimers, integrin clustering and 
phosphorylation of FAK [73]. Thus homooligomers were proposed to contribute to integrin 
activation and clustering. Combined with the mutagenesis study of αIIb TM domain, a push-pull 
model was proposed in which disruption of the / heterodimeric association of TM domains 
pushes the integrin to the activated state, whereas homooligomerization pulls the equilibrium 
toward activation [66]. Although integrin TM homooligomerization received support from 
computer modeling [74], it has not been observed using intact integrins on mammalian cell 
surface. Furthermore, the 3 G708N mutant was later found to increase ligand binding affinity as 
a consequence of increased affinity rather than valency [29]. Therefore, it is necessary to further 
test whether integrin TM domains form homooligomers during integrin activation and signaling. 
The Deadbolt Model 
As alternative or supplemental to the switchblade model, the “deadbolt” model posits that 
the association between the  I domain from the headpiece and -TD domain from the lower leg 
of  subunit is key to keep the integrin in the resting state, whereas dissociation of this interface 
results in release of the constraint of  I domain involved in ligand binding and allows it to 
undergo a subtle conformational change to shift the integrin to a high-affinity ligand binding 
state. Thus the extension is not critical for initial integrin activation, but rather a post-ligand-
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binding event in deadbolt model [34]. The model was also supported by many data [36, 75-78]. 
Additional structural analysis is necessary to evaluate these two models.  
IIb3 Outside-in Signaling 
       Outside-in signaling of αIIbβ3 is triggered by extracellular ligand binding, which promotes 
actin polymerization, cytoskeleton reorganization, and further cell spreading [7]. αIIbβ3 can bind 
several Arg-Gly-Asp (RGD)-containing ligands including fibrinogen, von Willebrand factor 
(vWF), vitronectin, fibronectin and thrombospondin. The ligand binding to αIIbβ3 involves 
specific regions on the headpiece from both αIIb and β3 subunits [19]. It is believed that integrin 
conformational rearrangements in outside-in signaling may occur in a similar way as in inside-
out signaling [15, 50, 58, 79]. In addition, the lateral association (clustering) of integrin 
heterodimers, which occurs as a consequence of multivalent ligand binding [80, 81], was shown 
to play a major role in outside-in signaling [82]. Although the exact mechanism for integrin 
clustering remains unclear, it seems to regulate activation of several kinases including FAK, Src 
and Syk [82-85]. Furthermore, the activated kinases phosphorylate the substrates leading to 
intracellular signaling (Fig.1.8) 
 
Figure 1.8 Working models of the integrin outside-in signaling. The  and  subunits are red and blue, 
respectively, and the membrane is shown as a gray line (modified from [28]).  
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An Overall Perspective 
Numerous studies from different labs suggest that integrin bidirectional signaling across 
the plasma membrane is accomplished by coupling extracellular conformational change to an 
unclasping and separation of the  and  TM and cytoplasmic domains. Based on the above 
description, we can summarize the basic conformational changes of integrins in their 
bidirectional signaling. For inside-out signaling, when cells are stimulated by agonists such as 
von Willebrand factor (VWF), thrombin and ADP, specific intracellular proteins, for example 
talin, can interact with integrin  cytoplasmic domains through its FERM domain [86], further 
initiating the separation of the cytoplasmic and TM domains. This event will destabilize the 
extracellular / tail interface, concomitantly perturbing the tail/head interface and facilitating 
the hybrid domain swing-out, which is coupled directly to the downward movement of the   I 
domain 7 helix and thus the MIDAS rearrangement [15, 38]. There must exist an equilibrium of 
different integrin conformational states in this process. The intracellular protein binding triggers 
the change of the integrin bent conformation toward the more extended conformation. Integrin 
conformational rearrangements may occur in a similar way for outside-in signaling [15, 50, 58, 
79]. Ligand binding stabilizes integrin in the extended conformation with open headpiece and 
two separate legs, resulting in the separation of the two cytoplasmic tails. Then, multivalent 
ligand binding brings several integrins close to each other, leading to integrin clustering, and 
kinases are recruited and activate each other, leading to intracellular signaling.  
Work presented in this dissertation demonstrates that disruption of /association, 
specifically, separation of two extracellular lower legs (IIb calf-2 domain and I-EGF4 
domain) that induces a global conformational change of integrins is critical for transmitting the 
bidirectional signals. Furthermore, the integrin TM homooligomerization was tested in order to 
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understand TM signaling and clustering. In contrast to previous work [23, 70, 73], we did not 
detect any homooligomers except for W967 mutant under various activating conditions. Our 
results therefore showed that disrupting integrin heterodimeric association of the 
TM/cytoplasmic domains and the extracellular legs, but not the formation of homomeric 
association, is critical for integrin activation and signaling. 
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Introduction 
             Integrins are heterodimeric cell adhesion receptors that transmit signals bidirectionally 
across the plasma membrane.  Together with other proteins, they mediate cell-cell and cell-
extracellular matrix interactions and communication.  As functionally important signalling 
molecules, they regulate a variety of cellular processes including growth, migration, 
differentiation, and survival.  Integrins are normally inactive on the surface of the cell.  When 
external agents stimulate cells, specific intracellular signals impinge on integrin cytoplasmic 
domains resulting in changes in structure and ligand-binding affinity in the integrin extracellular 
domain.  In turn, binding of multimeric ligands triggers outside-in signalling, leading to several 
cellular processes including cell spreading and kinase activation. Thus, integrin activation and 
signalling are dependent on specific allosteric conformational changes in the integrin on the cell 
surface. 
Integrin α and β subunits each have a large extracellular domain, a single transmembrane 
(TM) domain, and a short cytoplasmic domain (except the β4 subunit).  The association of the  
and  subunit TM/cytoplasmic tails is critical for maintaining integrins in the low-affinity state, 
whereas intracellular signals that destabilize  TM/cytoplasmic association result in integrin 
activation [1-7].  Recently, structures of both the complex and the isolated monomers of the 
TM/cytoplasmic domains were reported [8-11].  These structures show that in the resting state, 
ridge-in-groove packing of the TM domain and the GFFKR motif in the  subunit cytoplasmic 
domain are important for  association. Alternatively, integrins can be activated through the 
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binding of intracellular molecules such as talin [12], which dissociates the  TM/cytoplasmic 
domains and leads to a conformation with high affinity for ligands [2, 7, 13, 14].  
However, the mechanism of how activation signals are transmitted from the TM domain 
through two long extracellular legs to the ligand-binding headpiece remains elusive.  Two 
different models have been developed in attempts to define this mechanism.  The “deadbolt” 
model has been proposed in which interaction at a small interface between the -tail domain 
(βTD) CD loop (the deadbolt) and the  I domain 7 helix in Vβ3 ectodomain structure is 
critical for stabilizing integrins in the low-affinity state [15].  The inside-out signal causes the 
βTD CD loop to move away from the βI domain, enabling the 7 helix of the βI domain to 
displace from the ligand-binding pocket.  Thus, integrins assume high affinity for ligands even in 
the bent conformation [16].  This model suggests that overall conformational change is not 
critical for initial integrin activation, but rather a post-ligand-binding event.  The model was 
supported by transmission EM studies of the integrin V3 extracellular domain in complex 
with a fibronectin fragment [17], and a number of other studies [18-21].   However, one study 
that was designed to directly test this model found that deleting the CD loop residues, or 
mutating these residues to Ala had no effect on integrin ligand binding [22]. 
By contrast, the other model, the “switchblade” model, has gained more experimental 
support.  This model proposed that upon inside-out activation, the integrin extracellular domains 
rearrange through a “switchblade”-like movement to extend and assume high-affinity 
conformations for ligands [23].  It suggests that this extension of extracellular integrin domains 
is critical for integrin activation and signaling, since it preferentially places the ligand-binding 
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site away from the surface of the cell favoring ligand accessibility.  At the same time, extension 
enables hybrid domain swing-out, thus pulling the βI domain α7 helix through a crankshaft-like 
displacement, converting the headpiece from the closed, low-affinity state to the open, high-
affinity state [24].  This marked change in tertiary structure is supported by X-ray 
crystallography [25], electron microscopy (EM) [14, 23, 26, 27], solution X-ray scattering [28], 
antibody epitope mapping [29], and mutational studies [23, 28, 30-36].  However, the role of the 
two extracellular legs on integrin signaling remains elusive. Although the separation of the upper 
legs was observed by EM and crystal structures [23, 25], conformational change of the two lower 
legs is less defined.  Patients with mutations in calf-1 and calf-2 domains of αIIbβ3 showed 
Glanzmann thrombasthenia [37], implying the significance of this region. Recently, a disulfide 
bond introduced into α5β1 βTD and Calf-2 domain to restrict the leg separation blocked integrin 
extension and signaling [38]. 
In this chapter, we tested the role of integrin lower leg separation on integrin activation 
and signaling by introducing mutations that either prevent or disrupt the interface between the α-
subunit Calf-2 domain and β-subunit I-EGF4 domain (Fig. 2.1).  Our results showed that a 
disulfide bridge that prevents separation of this interface completely abolished integrin inside-out 
activation and outside-in signaling.  In contrast, introduction of an N-glycan that disrupts this 
interface resulted in high-affinity conformations.  The results indicate that the separation of the 
αβ legs is required for integrin activation and outside-in signaling.  
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Figure 2.1  Mutations in the IIb3 structure.  The Calf-2 domain is in pink, the I-EGF4 domain is in 
green, and the TD domain is in cyan.  A.  The mutations are located one domain N-terminal to the βTD 
CD loop (in salmon).  The ligand-binding I domain is in marine and the α7-helix is in purple.  Mutated 
residues shown with spheres are residues R751 (magenta) and N753 (red) of IIb, and Y594 (orange) and 
T603 (splitpea) of 3.  B.  The IIb_R751 (magenta) and 3_T603 (splitpea) are close to each other, and 
mutating them to cysteines was expected to form disulfide-linked heterodimer.  C.  The IIb N753 (red) 
and 3 Y594 (orange) are located at the interface, and introduction of a N-glycosylation site to these 
positions was predicted to disrupt  association.    
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Experimental  Procedures 
Cell Culture 
              HEK 293T cell line was purchased from American Type Culture Collection (ATCC, 
Manassas, VA) and was maintained in Dulbecco‟s modified Eagle‟s medium (DMEM) 
containing 10% fetal bovine serum (FBS) with 1X nonessential amino acids, 1X 
penicillin/streptomyosin, 1X L-glutamine, 1X sodium pyruvate (100X stock solutions were 
purchased from Invitrogen) at 37°C in 5% CO2 atmosphere. The total medium was changed 
every other day. 
Plasmid Construction, Expression, and Immunoprecipitation 
Plasmids with sequences encoding full-length human αIIb and β3 were subcloned into 
pEF/V5-HisA and pcDNA3.1/Myc-His (+), respectively [23].  The αIIb mutants F992A/F993A 
(activating GAAKR mutant, denoted as α*), F755T, and α*R751C and the β3 mutants 
Y594N/D596T and T603C were made using site-directed mutagenesis with the QuikChange kit 
(Stratagene, La Jolla, CA). Constructs were transfected into HEK293T cells (American Type 
Culture Collection, Manassas, VA) using a FuGENE transfection kit (Roche Applied Science, 
Indianapolis, IN) according to the manufacturer's instructions. To detect the expression levels of 
αIIb and β3 by flow cytometry staining, twenty-four or fourty-eight hours after transfection, cells 
were detached and suspended in Tris-buffered saline (TBS) supplemented with 5mM Ca
2+
. Then 
10 µg/ml of following monoclonal antibodies: AP3 (nonfunctional anti-β3 mAb, American Type 
Culture Collection), 7E3 (anti-β3 mAb), and 10E5 (anti-αIIb mAb, kindly provided by B. S. 
Coller, Rockefeller University, New York, NY) were incubated on ice for 30 min with the 
suspended cells separately, followed by staining of FITC conjugated anti-mouse IgG on ice for 
another 30 min. After wash, the samples were stored in phosphate-buffered saline (PBS) and 
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were subjected to FACS scans using a FACScalibur flow cytometer (Becton Dickinson, San 
Jose, CA, USA) from LSU School of Veterinary Medicine. To characterize disulfide-bond 
formation and glycosylation, twenty-four hours after transfection, the HEK293T cells were 
metabolically labeled with [
35
S] cysteine/methionine for 1.5 h before adding chase medium 
containing 500 μg/ml of cysteine and 100 μg/ml of methionine, and cells were cultured for 17 h 
and lysed in lysis buffer containing 20 mM Tris-buffered saline, pH 7.4 (TBS), supplemented 
with 1 mM Ca
2+
, 1% Triton X-100, and 0.1% Nonidet P-40 [3]. The lysates were 
immunoprecipitated with 1 µg of anti-β3 mAb AP3 and protein G-sepharose at 4°C for 1 h, 
eluted with 0.5% SDS.  After the addition of 1% Nonidet P-40, the protein was treated with or 
without 500 units of PNGase F (New England BioLabs) at 37°C for 1h.  Material was subjected 
to 7.5% nonreducing SDS-PAGE and fluorography [3]. 
Two-Color Ligand Binding Assay on HEK293T Transfectants 
Soluble binding of ligand mimetic IgM PAC-1 (BD Biosciences, San Jose, CA) and 
Alexa Fluor 488-labeled human fibrinogen (Enzyme Research Laboratories, South Bend, IN) 
was determined as previously described [31].  Briefly, transfected cells suspended in 20 mM 
HEPES-buffered saline, pH 7.4 (HBS) supplemented with 5.5 mM glucose and 1% bovine serum 
albumin were incubated on ice for 30 min with PAC-1 or Alexa Fluor 488-conjugated human 
fibrinogen in the presence of either 5 mM EDTA, 5 mM Ca
2+
, 100 µM Ca
2+
/1 mM Mn
2+
 plus 10 
µg/ml activating mAb PT25-2 (anti-αIIb, kindly provided by M. Handa, Keio University 
Hospital, Tokyo, Japan) [39], or 1 mM Mn
2+
 plus 10 µg/ml activating mAb LIBS-1 (anti-β3, 
kindly provided by M. H. Ginsberg, Scripps Research Institute, La Jolla, CA) [40].  For PAC-1 
binding, cells were washed and stained with FITC-conjugated anti-mouse IgM on ice for another 
30 min before being subjected to flow cytometry. Cells were also stained in parallel with Cy3-
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conjugated anti-β3 mAb AP3.  Binding activity is presented as the percentage of the mean 
fluorescence intensity (MFI) of PAC-1 or fibrinogen staining after background subtraction of the 
staining in the presence of EDTA, relative to the MFI of the AP3 staining. 
Ligand-Induced Binding Site (LIBS) Epitope Expression 
LIBS epitope expression was measured as previously described [31]. Briefly, transfected 
cells suspended in HBS supplemented with 5.5 mM glucose and 1% bovine serum albumin were 
incubated with or without 50 µM GRGDSP peptide in the presence of 1 mM Mn
2+
 plus 10 µg/ml 
anti-LIBS antibody.  After incubation on ice for 30 min, cells were washed and stained with 
FITC-labeled anti-mouse IgG on ice for 30 min.  The stained cells were subjected to flow 
cytometry, and LIBS epitope expression was expressed as the percentage of MFI of anti-LIBS 
antibody relative to MFI of the conformation-independent anti-β3 mAb AP3. 
Cell Adhesion Assays 
Cell adhesion on immobilized human fibrinogen was assessed by the measurement of 
cellular lactate dehydrogenase (LDH) activity as previously described [41].  Briefly, cells 
suspended in HBS supplemented with 5.5 mM glucose and 1% bovine serum albumin and 1 mM 
Ca
2+
 with or without 1mM DTT were added into flat bottom 12-well plates (1 × 10
5
 cells/well) 
precoated with 20 µg/ml fibrinogen and blocked with 1% bovine serum albumin.  After 
incubation at 37°C for 1 h, wells were washed three times with HBS supplemented as indicated 
above.  Remaining adherent cells were lysed with 1% Triton X-100, and LDH activity was 
assayed using the Cytotoxicity Detection Kit (Roche Applied Science) according to the 
manufacturer's instructions.  Cell adhesion was expressed as a percentage of bound cells relative 
to total input cells. 
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Cell Spreading and Microscopy 
Glass bottom 6-well plates (MatTek Corporation, Ashland, MA ) were coated with 20 
µg/mL human fibrinogen in phosphate-buffered saline at pH 7.4 (PBS) overnight at 4°C, and 
then blocked with 1% BSA at room temperature (RT) for 1 h.  The transiently transfected 
HEK293T cells were detached with trypsin/EDTA, washed three times with DMEM, and seeded 
on fibrinogen-coated plates with or without 1mM DTT.  After incubation at 37°C for 1 h, cells 
were washed three times with PBS and fixed with 3.7% formaldehyde in PBS at RT for 10 
minutes for microscopy.  
Differential interference contrast (DIC) imaging was conducted on a Leica TCS SP2 
spectral confocal system coupled to a DM IRE2 inverted microscope with a 63X oil objective.  
For the quantification of cell spreading area, outlines of 100 randomly selected adherent cells 
were generated, and the number of pixels contained within each of these regions was measured 
using ImageJ software (Bethesda, Maryland). 
Results 
Mutations of IIb3 Extracellular Membrane-Proximal Stalk Stabilizes or Disrupts αβ Leg 
Association 
 
To test whether the conformational rearrangements of integrin lower legs are important, 
we designed mutations at the interface between the αIIb-subunit Calf-2 domain and the β3-
subunit I-EGF4 domain (Fig. 2.1).  To mimic integrin inside-out activation, site-directed 
mutagenesis was used to mutate two phenylalanine residues in the GFFKR motif of the αIIb 
cytoplasmic domain to alanines (αIIb_F992A/F993A/β3, denoted α*/β).  Cysteine residues were 
introduced into the α*/β construct to test the effects of a disulfide-bridged mutant on integrin 
inside-out signaling [3].  The distance between Cβ atoms of αIIb-subunit Arg751 and β3-subunit 
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Thr603
 in the αIIbβ3 crystal structure is 4.1 Å [42].  Therefore, cysteine residues introduced to 
replace these two residues (α*_R751C/β3_T603C, denoted α*751C/β603C) were expected to 
form a disulfide bond.   
In addition to introducing this disulfide clasp to prevent the αβ dissociation, we also 
designed mutations to disrupt this interface to determine whether disrupting the αβ leg 
association affected ligand binding.  N-glycosylation sites were introduced on the αIIb-subunit 
Calf-2 domain and on the β3-subunit I-EGF4 domain.  In the crystal structure, the IIb_N753 
and 3_Y594 residues are at the interface between the Calf-2 and I-EGF4 domains (Fig. 2.1C) 
and were predicted to be important for the  association.  Therefore, introducing an N-glycan 
chain to either residue was expected to disrupt the  association.  The following mutants were 
constructed to test this hypothesis: IIb_F755T/β3 (denoted F755T/β, resulting in N-
glycosylation of N753 in αIIb) and αIIb/3_Y594N/D596T (denoted α/(Y594N/D596T), 
resulting in N-glycosylation of Y594N in β3). 
Expression of Wild Type and Mutant αIIbβ3 on HEK293T Cells 
To determine the expression of wild type and mutant αIIbβ3, wild type and four mutated 
αIIb and β3 subunits were co-transfected into HEK293T cells and subjected to immunostaining 
flow cytometry (Fig. 2.2A).  Two anti-β3 antibodies AP3 and 7E3, which recognize the β3 I and 
hybrid domains, respectively, and one anti-IIb antibody 10E5, which recognizes the β-propeller 
domain, were used to monitor cell surface expression. Wild-type and mutant integrins bound to 
the three antibodies (Fig. 2.2A), suggesting that they adopted a native conformation on the cell 
surface.  To exclude the possible contribution of endogenous αV in HEK293T cell lines, β3 
integrin alone was transfected into the cells, and none of these three antibodies bound (Fig. 
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2.2A), suggesting that this cell line does not express endogenous αV integrin.  Indeed, no αV 
expression was detected by using the anti-αV antibody LM609 (data not shown). 
 
Figure 2.2  Expression and immunoprecipitation of wild-type and mutant IIb3 integrins.  A.  
Immunofluorescent flow cytometry.  HEK293T transfectants were labeled with AP3 (anti-3), 7E3 (anti-
3), and 10E5 (anti-IIb).  Thick and thin lines show labeling of the IIb3 transfectant and the mock 
transfectant, respectively.  B.  Immunoprecipitation.  Lysates from 
35
S-labeled HEK293T cell 
transfectants were immunoprecipitated with mAb AP3.  Precipitates were subjected to nonreducing 7.5% 
SDS-PAGE and fluorography. 
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Nonreducing SDS-PAGE of 
35
S-labeled, immunoprecipitated receptors showed that in 
the activating mutant (Fig. 2.2B, lane 2), the α* and the β3 subunits migrated in a similar pattern 
to the wild-type receptor (denoted α/β, Fig. 2.2B, lane 1).  In comparison, the receptors with the 
pair of cysteine mutants α*_R751C/β3_T603C formed a disulfide-linked receptor (Fig. 2.2B, 
lane 3), and the efficiency of the disulfide-bond formation was close to 100%.  The β3 subunit of 
β3-glycosylated mutant α/(Y594N/D596T) (Fig. 2.2B, lane 4) migrated slightly slower than that 
of the wild type (Fig. 2.2B, lane 1), whereas the αIIb subunit from this glycosylation mutant 
migrated in a similar pattern to the wild type αIIb subunit, suggesting that there was an additional 
glycan chain added only to the β3-subunit. For the αIIb-glycosylation mutant F755T/β (Fig. 
2.2B, lane 5), the β3 subunit migrated in a similar pattern to the wild-type β3 (Fig. 2.2B, lane 1), 
whereas the mutated αIIb subunit (Fig. 2.2B, lane 5) migrated slightly slower than its wild-type 
counterpart (Fig. 2.2B, lane 1), consistent with the presence of an additional glycan chain.  
Furthermore, these differences  between the wild-type and glycosylation mutants disappeared on 
deglycosylation by PNGase F (Fig. 2.2B, lanes 6-8), confirming the attachment of extra glycan 
chains. 
Separation of the α-subunit Calf-2 Domain and the β-subunit I-EGF4 Domain Is Required 
for Integrin Inside-out Signaling 
 
Integrin inside-out signals are transmitted from the cytoplasmic/TM domains to the 
extracellular domains, leading to the conformational change of the ligand-binding headpiece, 
resulting in high-affinity ligand binding.  To study the role of the separation of the αIIb-subunit 
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Calf-2 domain and the β3-subunit I-EGF4 domain in integrin activation, two-color flow 
cytometry was used to determine the binding of the soluble ligand-mimetic antibody PAC-1 and 
fibrinogen to the wild-type and mutant receptors on the HEK293 cell surface [4].  As shown in 
Figure 3A, the expression level of receptors was monitored by the Cy3-labeled anti-β3 antibody 
AP3.  The Cy3-AP3 fluorescence intensity was divided into four domains that represented 
specifically labeled receptors.  The R1 and R2 domains contained cells designated as positive 
expressers.  Ligand binding affinity was monitored by the FITC-labeled PAC-1.  Cells located in 
the R2 and R4 domains are those with high-affinity ligand binding.  In the presence of Ca
2+
, very 
few cells with the wild-type αIIbβ3 (α/β) were located in the R2 domain, and most positive 
expressers were in the R1 domain, indicating that wild-type αIIbβ3 bound very little ligand-
mimetic PAC-1antibody. This is consistent with a low-affinity conformation under these 
physiological conditions.  In the presence of Mn
2+
 and activating antibodies PT25-2, most 
positive expressers shifted to the R2 domain, indicating that wild-type αIIbβ3 bound PAC-1 with 
high affinity (Fig. 2.3A).  When the GFFKR motif of the αIIb was mutated to GAAKR, the 
mutant receptor (α*/β) bound PAC-1 with high affinity even in the presence of Ca2+, since most 
positive expressers were located in the R2 domain (Fig. 2.3A).  The addition of the PT25-2 
activating antibody did not change this pattern (Fig. 2.3A), suggesting that the GAAKR mutation 
mimics integrin inside-out activation.  When a disulfide bond was introduced to this activating 
mutant (α*751C/ β603C), the ligand binding affinity in the presence of Ca2+ was reversed and a  
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Figure 2.3  Ligand-binding activity of wild-type and mutant IIb3 integrins.  A.  Flow cytometry of 
dot plots.  B and C.  Quantified soluble ligand-binding affinity.  Cells were incubated with PAC-1 (A-B) 
in the presence of 5 mM Ca
2+
 or 10 µg/ml PT25-2 plus 1 mM Ca
2+
, or FITC-fibrinogen (C) in the 
presence of 5 mM Ca
2+
 or 10 µg/ml LIBS1 plus 100 µM Ca
2+
 and 1 mM Mn
2+
 as indicated.  Binding 
activities were determined by flow cytometry and expressed as described in Materials and Methods.   
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majority of the positive expressers were located in the R1 domain (Fig. 2.3A), indicating that 
preventing separation of the αβ legs by a disulfide bond abolishes the integrin inside-out 
activation.  In contrast, the two glycosylation mutants α/(Y594N/D596T) and F755T/β bound 
PAC-1 with high affinity in the presence of Ca
2+ 
alone, with most positive expressers located in 
the R2 domain (Fig. 2.3A).  The addition of the PT25-2 activating antibody did not influence 
their ligand binding, suggesting that these two mutants constitutively bound ligand with maximal 
affinity (Fig. 2.3A).  
Figure 2.3B quantifies this data by measuring the MFI of FITC-labeled PAC-1.  The 
results confirmed that the wild-type receptor bound PAC-1 only in the presence of activating 
conditions, whereas the GAAKR mutant bound PAC-1 constitutively even in the presence of 
Ca
2+ 
alone (Fig. 2.3B).  The disulfide-bonded receptor reversed the GAAKR-induced inside-out 
activation, but did not abolish the activating antibody-induced ligand binding. When N-glycan 
chain was introduced into the αβ interface of either subunit, receptors bound PAC-1 
constitutively (Fig. 2.3B).  Soluble fibrinogen binding was also carried out and similar results 
and conclusion were obtained (Fig. 2.3C).  Taken together, these experiments suggest that 
separation of the αβ lower legs is required and sufficient for integrin inside-out activation. 
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Disruption of the Interface between the α-subunit Calf-2 Domain and the β-subunit I-EGF4 
Domain Causes a Global Integrin Conformational Change 
 
Priming and ligand binding induce IIbβ3 conformational changes that expose the LIBS 
epitopes.  LIBS epitopes are at the interfaces between the headpiece and tailpiece and between 
the  and β legs so that they are buried in the bent conformation but exposed in the extended 
conformation [23, 29].  To investigate the conformational state of the αIIbβ3 mutants, binding of 
anti-3 LIBS mAb LIBS1 [43] was analyzed.  The LIBS1 bound poorly to wild-type αIIbβ3 in 
the presence of Ca
2+
 alone.  The binding significantly increased when Mn
2+
 and the ligand 
mimetic peptide GRGDSP were added (Fig. 2.4), suggesting that the ligand mimetic peptide 
stabilizes integrins in the more extended conformation.  The GAAKR mutant (α*/β) bound 
LIBS1 better than the wild type in the presence of Ca
2+
 alone, suggesting that the mutation 
mimicking inside-out signaling shifts the integrin towards a more extended conformation.  
Addition of Mn
2+
 and GRGDSP peptide further increased binding of the GAAKR mutant to 
LIBS1, indicating that this mutation cannot stabilize integrins in the fully extended and open 
state.  In comparison, introducing the disulfide-bond into this mutant (α*751C/β603C) slightly 
decreased LIBS1 binding in the presence of Ca
2+
 (Fig. 2.4), suggesting that the disulfide-bridge 
reverses the conformational change induced by inside-out activation.  In contrast to the wild-type 
and the GAAKR mutant receptors, the two glycosylation mutants (α/Y594N/D596T and 
F755T/β ) bound LIBS1 in the presence of Ca2+ (Fig. 2.4), suggesting that separation of the two 
legs stabilizes integrins in a more extended conformation.  Thus, this conformational change 
could explain their high-affinity ligand binding. 
44 
 
Figure 2.4  Exposure of the LIBS1 eptitope.  Cells were stained with anti-LIBS antibody LIBS1 in the 
presence of 5 mM Ca
2+
 or 1 mM Mn
2+
 plus 50 µM RGD peptides (GRGDSP).  LIBS epitope exposure 
was determined as the percentage of MFI of anti-LIBS1 antibody relative to non-functional anti-3 mAb 
AP3.  Error bars are standard deviation (SD).  
 
Separation of the α-subunit Calf-2 Domain and the β-subunit I-EGF4 Domain Is Crucial 
for Cell-Adhesion and Spreading 
 
We further determined how separation of the α-subunit Calf-2 domain and the β-subunit 
I-EGF4 domain affects outside-in signaling by assaying cell adhesion and spreading.  HEK293T 
cells transiently transfected with wild-type and mutant αIIbβ3 were seeded on fibrinogen-
precoated dish surfaces at 37°C for 1 h.  The amount of adherent cells was assessed by 
quantifying the cellular lactate dehydrogenase (LDH) activity.  The results showed that in 
contrast to previous studies in CHO transfectants [32, 41], all mutants with higher affinity for 
soluble ligands adhered to immobilized fibrinogen similarly to the wild-type cells.  This suggests 
that the αIIbβ3 integrins in HEK293T cells are more active than similar integrins in CHO cells.  
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In contrast, HEK293T cells transfected with a TM disulfide-bonded αIIbβ3 (α968C/β693C) 
showed much less adhesion than those with a wild-type receptor (Fig. 2.5A).  It is not surprising 
that the disulfide bonded mutant (α*751C/β603C), which restricts separation of the αβ legs, 
exhibited less adhesion compared to the activating mutant (α*/β) (Fig. 2.5A), since the adhesion 
strength is dependent not only on the affinity of the receptors, but also on the spreading of the 
cells on the immobilized ligands.  As shown below, the disulfide-bonded mutants had defective 
cell spreading, resulting in easier detachment of cells during washing.  When these two disulfide-
bonded mutants were treated with DTT, the cell adhesion ability was recovered to the similar 
level of the wild type with DTT.  
To test if separation of the αβ lower leg can affect cell spreading, HEK293T transient 
transfectants were coated on immobilized fibrinogen at 37°C for 1 h, followed by fixation and 
microscopic analysis.  Cells transfected with wild-type receptor demonstrated cell adhesion and 
cell spreading (Fig. 2.5B).  Previously, the TM disulfide-bonded αIIbβ3 (α968C/ β693C) in CHO 
transfectants exhibited defective spreading, indicating that separation of the TM domains is 
required for integrin outside-in signaling [41].  We confirmed that this disulfide-bonded mutant 
in HEK293T cells exhibited similar defective spreading on fibrinogen (Fig. 2.5B), and even 
though some cell could adhere to the immobilized fibrinogen, they remained round and did not 
change size.  The cell area was quantified, and showed that the disulfide-bonded mutant had a 
significant decrease in adherent cell size comparing to that of the wild type (Fig. 2.5C).  Thus, 
this mutant was used as a negative control (Fig. 2.5B and C).  As we discussed in our previous 
paper [41], failure of outside-in signaling of the disulfide-bonded mutant was not likely due to 
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the failure to bind ligands, since the mutant could bind ligands with similar level as the wild-type 
(Fig. 2.3).  The GAAKR mutant had little effect on cell spreading or on cell shape and size.  By 
comparison, the disulfide bonded mutant (α*751C/ β603C) had defective spreading (Fig. 2.5B 
and C). Most adherent cells remained round and stayed the same size (Fig. 2.5B). To 
demonstrate that the defect in spreading was due to the disulfide linkage, we treated the cells 
with 1 mM DTT.  Such treatment has shown to reduce the majority of engineered disulfides in 
the mutant receptor and rescued cell spreading of the TM linkage (Fig. 2.5B and C) [41].  
Similarly, the DTT treatment of the disulfide-bonded integrin α*751C/ β603C led to a rescue of 
cell spreading (Fig. 2.5B and C).  The effect of DTT treatment was unlikely due to the direct 
effect on ligand binding affinity because DTT had little effect on wild-type cell adhesion and 
spreading (Fig. 2.5). The quantitative adherent cell area of the disulfide bonded mutant cells 
decreased by greater than 30% of that of the wild-type cells and of the GAAKR mutant cells.  
This suggests that separation of the α/β lower leg is crucial for cell spreading.  HEK293T cells 
transfected with either glycosylation mutant could adhere to immobilized fibrinogen and 
demonstrated substantial spreading (Fig. 2.5C).  However, more glycosylation mutant cells than 
wild-type cells remained round (Fig. 2.5B), suggesting that high-affinity mutants may have some 
defective effect on outside-in signaling probably due to their effect on cell detachment.  Further 
research is required to determine the exact molecular mechanism of this defect. 
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Figure 2.5 Cell adhesion and spreading.  A.  Adhesion of HEK293T transfectants in the presence of 
1mM Ca
2+
 with or without DTT (1mM) to surfaces coated with 20 µg/ml fibrinogen.  The amount of 
bound cells was determined by measuring LDH activity as described in Materials and Methods.  Data are 
representative of three independent experiments, each in triplicate.  B.  DIC images of HEK293T 
transfectants after adhering to immobilized fibrinogen at 37°C. a: /; b: / + DTT; c: α*/ β; d: α*751C/ 
β603C; e: α*751C/ β603C + DTT; f: α/(Y594N/ D596T); g: F755T/ β; h: α968C/ β893C; i: α968C/ 
β893C + DTT. The images are representatives of three independent experiments.  Scale bar represents 10 
µm.  C.  Quantification of the areas of adhering/spreading cells as described in Materials and Methods.  
Error bars are SD.  *** P <0.001.  
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Discussion 
  When cells are activated, binding of intracellular molecules such as talin, dissociates the 
 TM/cytoplasmic domains and leads to integrin activation.  The current study demonstrates 
that separation of the interface between the α-subunit Calf-2 domain and the β-subunit I-EGF4 
domain is required for both integrin inside-out activation and outside-in signaling.  It suggests 
that the dissociation of the  TM/cytoplasmic domains is coupled with the dissociation of the 
extracellular αβ lower legs, specifically, the interface between the α-subunit Calf-2 domain and 
the β-subunit I-EGF4 domain. The mechanism by which this dissociation affects the 
conformational change of the upper legs and ligand-binding headpiece leading to high-affinity 
ligand binding remains to be determined.   
 When disulfide was introduced to the calf-2 and I-EGF4 interface, the mutant receptor 
could be activated from outside by external reagents such as Mn
2+
 and activating antibodies. In 
addition, LIBS epitope was exposed upon RGD binding, suggesting that the disulfide-bonded 
mutant could adopt an extended conformation. Similar results were obtained when a disulfide 
bond was introduced to the IIb3 TM domain [3, 41]. This is probably because of the highly 
flexible 3 leg as suggested in the crystal structure [42]. Interestingly, when a disulfide bond was 
introduced to the 51 calf-2 and TD interface, the mutant 51 failed to be extended.  The 
discrepancy may be due to the varied role of different interface on integrin activation, or due to 
different integrin families.  While the 3 integrins must response rapidly to environment [44], 
changing their conformation within seconds from their default low affinity state to high affinity 
state, the 1 integrins do not require a rigid control of their affinity [38]. 
It is still controversial whether integrin extension is required for integrin activation and 
signaling. A cryoelectron tomography study showed that the IIb3 remains the same height 
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after Mn
2+
 activation [20]. However, for particles the size of integrins, cryo-EM cannot 
distinguish between a particle in two different orientations or two different conformations [45].  
Since preparations of integrins, including αIIbβ3, often contain a mixture of particles with 
different conformations [23, 42], the intermediate αIIbβ3 conformation may have resulted from 
averaging particles together in extended and bent conformations [24].  In addition, it has been 
shown that the activation of IIb3 by Mn
2+
 is limited [46], and the presence of Mn
2+
 might not 
induce any global conformational changes, but may result in integrin aggregation, which would 
complicate the samples for EM study.  Recently, fluorescence lifetime imaging microscopy of 
integrin αVβ3 on live cells indicated that integrins were in the bent conformation and no 
extension occurred upon activation [21]. But similar to the cryo-EM image [46], this study may 
just represent an average of all conformational states of integrins on the cell surface, and the 
method might not be sensitive enough to monitor conformational change of a small portion of 
integrin molecules.  On the other hand, negative-staining EM studies of integrin αVβ3 [23], 
αIIbβ3 [42], and αXβ2 [27, 47] showed that a substantial amount of integrin molecules were in 
the extended conformation.  Sklar and colleagues used FRET to measure the distance between an 
FITC-labeled ligand-mimetic peptide bound to integrin 41 as the donor and a plasma 
membrane dye as the acceptor [48], and showed that integrins extend about 50 Ǻ converting 
between the resting and Mn
2+
-activated states.  This distance is much less than the fully extended 
conformational change, which will result in an approximately 200-Ǻ change.  Therefore, the 
study suggests that full extension is not necessary for integrin activation.  Recently, Blue et al. 
[49] introduced a disulfide bond between the IIb calf-1 and thigh domain to limit integrin 
extension. They showed that this mutant had reduced ability to bind large ligands, suggesting 
that integrin extension is important for ligand accessibility.  Most interestingly, Ye et al. (2010) 
utilized negatively-stained EM to study the conformational states of integrin αIIbβ3 embedded in 
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phospholipid nanodiscs activated by the talin head domain. They showed that about 22% of 
integrins in nanodiscs in the presence of the talin head domain were in the extended 
conformation in the absence of other membrane proteins [14].  Binding of the talin head domain 
is sufficient to shift the equilibrium towards extension, even though not all molecules are 
stabilized in the fully extended state. Taken together, these studies suggest that when integrins 
are activated by intracellular signals, equilibrium of different integrin conformers is shifted 
toward a more extended state.  However, the full extension of activated integrins may not be 
necessary for ligand binding on the cell surface.   
In the present study, the inside-out activation by GAAKR mutation only slightly exposed 
the LIBS1 epitope (Fig. 2.4), and addition of a ligand-mimetic peptide further exposed the 
epitope, suggesting that this inside-out activation does not induce full extension of all integrin 
molecules.  Inside-out activating signals may act by shifting the equilibrium, but not stabilizing 
integrins in the fully extended state, which represents an extreme conformation.  However, this 
equilibrium shift is sufficient to initiate ligand binding.  Regardless of the extent of integrin 
extension, separation of the TM/cytoplasmic tails [3, 13, 14, 50] and dissociation of the lower αβ 
legs as observed in the present and previous [38] studies are required for the transmission of the 
inside-out signals to the ligand-binding headpiece. This observation is consistent with a previous 
crystallography study of the complete ectodomain of integrin αIIbβ3 [42], which suggested that 
breathing motions at the lower α and β legs might be a pathway for integrin extension, and this 
motion shifts equilibrium towards a more extended and higher affinity states.  EM studies of 
three integrin families showed that the legs of the extended integrins are often crossed at the α 
and β genu region [14, 23, 27, 42], suggesting that more structural assessments are needed to 
determine how signals are conveyed between the headpiece and the lower legs. 
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Outside-in signaling is induced by binding of integrins to multimeric ligands, which 
results in integrin conformational change and clustering, both of which are critical for signaling.  
A number of studies showed that binding of ligands or ligand-mimetic peptides stabilizes 
integrins in the more extended conformation [23, 27, 42, 47].  However, it is not known whether 
integrins assume a fully extended conformation on the cell surface upon ligand binding in the 
physiological conditions.  It is evident from the present study and previous publications that 
dissociation of the lowerαβ legs and the TM/cytoplasmic tails is required for this signal 
transduction.   
         In conclusion, our study strongly suggests that a global conformational change is required 
to transmit integrin inside-out activation.  Introduction of a glycan chain to dissociate the αβ 
lower legs lead to both a high-affinity ligand binding state and a global conformational change, 
whereas introduction of a disulfide bond to restrict the dissociation abolishes both inside-out and 
outside-in signaling.  Thus, this interface lies within the critical pathway of integrin bidirectional 
signaling.  
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TEST OF THE INTEGRIN TRANSMEMBRANE DOMAIN 
HOMOOLIGOMERIZATION DURING INTEGRIN  
LIGAND BINDING AND SIGNALING 
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Introduction 
Integrins are cell adhesion molecules that are essential for many biological functions such 
as cell migration, survival and differentiation. These functions are accomplished by integrin 
bidirectional signalling across the cell membrane.  Inside-out activation occurs when specific 
intracellular molecules such as talin and kindlin bind to the integrin cytoplasmic domain, leading 
to the integrin conformational change and therefore high affinity for extracellular ligands. Then, 
binding of multimeric extracellular ligands results in outside-in signalling that is critical for 
many cellular processes. It has been shown that integrin bidirectional signal transduction requires 
integrin structural change and lateral distribution (clustering). 
Integrins are type I transmembrane (TM) proteins consisting of two non-covalently 
associated  and  subunits, each with a large extracellular domain, a single spanning TM 
domain and a short cytoplasmic domain. Recent structural studies have greatly advanced our 
understanding of how integrin assumes conformational change during inside-out activation [1-4]. 
Even though relatively short, the integrin TM/cytoplasmic domains play a crucial role in this 
process. It has been shown that the association of  and  subunit TM/cytoplasmic domains is 
critical for stabilizing integrins in the resting state [5-8]. When induced by binding of the  
subunit cytoplasmic domain through talin or other intracellular molecules, the TM/cytoplasmic 
domains separate, driving integrin extension and shifting the ligand-binding / headpiece to an 
open, high-affinity conformation [4, 9]. Recently, the structure of the TM/cytoplasmic domains 
in the resting state was proposed based on Rosetta computational modeling and experimental 
data using intact integrins on mammalian cell surface [8]. In this structure, the IIb GXXXG 
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motif and their 3 counterparts of the transmembrane domains associate with ridge-in-groove 
packing, and the IIb GFFKR motif and the 3 Lys-716 in the cytoplasmic segments play a 
critical role in the / association. The structures of the complex and monomeric  and  subunit 
TM/cytoplasmic domains have also been solved by NMR [10-12]. These studies have shed light 
on structural basis of integrin TM/cytoplasmic domain signaling across the plasma membrane 
[13]. 
In contrast to the role of the heterodimeric TM/cytoplasmic domain association and 
dissociation, that of homooligomerization of integrin TM domains in integrin signaling remains 
elusive. In 2001, NMR study in this region by Li et al. failed to detect the heterodimeric 
association between the  and  subunit TM/cytoplasmic domains using TM/cytoplasmic 
fragment peptides in micelles. Instead, they observed that the  and  fragments tend to form 
homodimers and homotrimers, respectively [14]. Later, αIIb and β3 TM helices were confirmed 
to form homooligomers in bacterial membranes using TOXCAT assay [15, 16]. The  and  
homomeric interactions have been widely studied by computational modeling [17-19]. These 
studies showed that the homooligomerization interface and the heterodimerization motifs largely 
overlap, but it seems that homomeric interaction is less specific than the heterodimeric 
interaction [16]. In 2003, asparagine mutagenesis study in the TM region of β3 subunit (with 
most experiments on the mutation 3_G708N) suggests that TM homooligomerization 
contributes to integrin activation and clustering [20].  However, the mutation 3_G708N, which 
was reported to enhance trimerization in detergent and increase ligand binding avidity in the 
transfected CHO cells [20], was later found to activate the integrin by changing ligand binding 
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affinity rather than valency [7]. Furthermore, mutations that disrupted homodimerization of 
integrin TM domains, which also disrupted heterodimerization since two interfaces overlap, were 
shown to activate integrins for ligand binding, suggesting that TM domain separation is 
sufficient to activate integrins [21]. Therefore, it was proposed that integrin TM 
homooligomerization is not a critical step for inside-out activation, but instead, it may help to 
stabilize the integrin in the high affinity state [15]. 
It has been shown that integrin outside-in signaling requires both conformational change 
and clustering of integrins. However, the mechanism of how integrins transmit these signals 
across the plasma membrane through the TM/cytoplasmic domains remains unknown. More 
specifically, it is unclear whether integrin TM homooligomerization plays any role in integrin 
clustering and signaling, even though it has been proposed that it provides structural basis for 
this process. Importantly, although  and  TM homooligomerization was found in micelles and 
bacterial cell membrane [14, 16, 20-22], it has never been observed in mammalian cell 
membrane using full-length integrins. In this paper, we tested whether integrin TM domains 
form homooligomers in mammalian cell membrane using disulfide scanning of the intact integrin 
IIb3. Our results showed that integrin TM domains do not form homooligomers before or 
after soluble ligand binding or during integrin bidirectional signaling.  
Experimental Procedures 
Plasmid Construction and Transient Transfection 
Plasmids coding for full-length human αIIb and β3 were subcloned into pEF/V5-HisA 
and pcDNA3.1/Myc-His (+), respectively [23]. Amino acid substitution in TM and TM proximal 
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regions to cysteine was made using site-directed mutagenesis with the QuikChange kit 
(Stratagene). Constructs were transfected into 293T cells (American Type Culture Collection, 
Manassas, VA) using a Fugene transfection kit (Roche Applied Science, Indianapolis, IN) 
according to the manufacturer's instructions.  
Immunoprecipitation 
Twenty-four hours after transfection, 293T cells were treated with 20 μg/ml 2-
Bromopalmitate (2-BP), metabolically labeled with [
35
S] cysteine/methionine for 1.5 h before 
adding chase medium containing 500 μg/ml of cysteine and 100 μg/ml of methionine, and cells 
were cultured 17 h overnight [6]. Then cells were detached and suspended in Tris-buffered saline 
(TBS) (10
6
 cells in 100 μl) supplemented with 5 mM Ca2+, 1 mM Mn2+ with 3mg/ml fibrinogen 
or 1 mM Mn
2+
 with 50 M RGD peptide and incubated at room temperature for 30 minutes. 
Then, saponin was added to a final concentration of 0.02%, and  20 μM CuSO4/100 μM o-
phenanthroline was added by 10-fold dilution from stock solutions, and cells were incubated on 
ice for 10 min. Oxidation was quenched by adding an equal volume of TBS containing Ca
2+
 and 
5 mM N-ethyl maleimide. Cells were lysed by addition of an equal volume of 2% Triton X-100 
and 0.1% NP-40 in the same buffer for 10 min on ice. Cell lysate was centrifuged and 
immunoprecipitated with 1 g of anti-β3 mAb AP3 and protein G Sepharose at 4 °C for 2 h. 
After three washes with lysis buffer, precipitated integrin was dissolved into 0.5% SDS sample 
buffer and subjected to nonreducing 7.5% SDS-PAGE and fluorography [6].  
For IIb W967C mutant, 2 mM DTT was added to the [35S]-labeled cells and incubated 
at 37°C for 10 min, washed twice with TBS and then oxidized by Cu-phenanthroline on ice for 
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10 min.  Oxidation was quenched by adding an equal volume of TBS containing Ca
2+
 and 5 mM 
N-ethyl maleimide. Cells were lysed and integrins were immunoprecipitated as described above. 
To test whether integrins form homomeric disulfide bond after adhering to the 
immobilized fibrinogen, [
35
S]-labeled cells were seeded on the surface of 6-well plates pre-
coated with immobilized fibrinogen and incubated at 37°C for 1hr. After washing twice with 
TBS, adherent cells were incubated on ice with Cu-phenanthroline and saponin and quenched 
with 5 mM N-ethyl maleimide. Cells were lysed and integrins were immunoprecipitated as 
described above. 
Ligand-induced Binding Site (LIBS) Epitope Expression 
LIBS epitope expression was measured as described [24]. Briefly, transfected cells 
suspended in HBS supplemented with 5.5 mm glucose and 1% bovine serum albumin were 
incubated either with 5 mM Ca
2+, 3mg/ml fibrinogen or 50 μM Gly-Arg-Gly-Asp-Ser-Pro 
peptide (GRGDSP) in the presence of 1 mM Mn
2+
 at 37°C for 15min, and then 10 μg/ml anti-
LIBS1 antibody was added. After incubation on ice for 30 min, cells were washed and stained 
with FITC-labeled anti-mouse IgG on ice for 30 min. The stained cells were subjected to flow 
cytometry, and LIBS epitope expression was expressed as the percentage of MFI of anti-LIBS 
antibody relative to MFI of the conformation-independent anti-β3 mAb AP3. 
Cell Spreading, Integrin Clustering and Microscopy 
Glass bottom 6-well plates (MatTek Corporation, Ashland, MA) were coated overnight at 
4°C with 20 µg/ml human fibrinogen in phosphate-buffered saline at pH 7.4 (PBS), followed by 
blocking with 1% BSA at room temperature (RT) for 1 h. The transiently transfected HEK293T 
cells were detached by trypsin/EDTA, washed three times with DMEM. Cells were seeded on 
fibrinogen-coated dishes. After incubation at 37°C for 1 hour, cells were washed 3 times with 
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PBS and fixed with 3.7% formaldehyde in PBS at RT for 10 minutes, or for integrin clustering, 
10μg/ml anti-β3 mAb AP3 was added at room temperature for 30 minutes, followed by staining 
with 10μg/ml FITC-conjugated goat anti-mouse IgG for 30 minutes at room temperature before 
fixation. 400nM cytochalasin-D was added as control before seeding. 
Differential interference contrast (DIC) imaging was conducted on a Leica TCS SP2 
spectral confocal system, coupled to DM IRE2 inverted microscope with 63X oil objective. For 
the quantification of cell spreading area, outlines of randomly selected 100 adherent cells were 
generated and the number of pixels contained within each of these regions was measured using 
ImageJ software (Bethesda, Maryland). 
Cell Adhension 
Cell adhesion on immobilized human fibrinogen was assessed by the measurement of 
cellular lactate dehydrogenase (LDH) activity as described [25]. Briefly, cells suspended in HPS 
supplemented with 5.5 mM glucose, 1% bovine serum albumin and 1 mm Ca
2+
  were added into 
flat bottom 12-well plates (1 × 10
5
 cells/well) that had been precoated with 20ug/ml fibrinogen 
and blocked with 1% bovine serum albumin. After incubation at 37 °C for 1 h, wells were 
washed three times with HBS supplemented as indicated above. Remaining adherent cells were 
lysed with 1% Triton X-100, and lactate dehydrogenase activity was assayed using the 
Cytotoxicity Detection Kit (LDH) (Roche Applied Science) according to the manufacturer's 
instructions.  Cell adhesion was expressed as a percentage of bound cells relative to total input 
cells. 
Results 
Integrin TM Domains Do Not Form Homooligomers Before or After Soluble Ligand 
Binding  
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Previously, cysteine mutagenesis and heterodimeric disulfide scanning were used to 
successfully identify the integrin IIb and 3 TM interface in mammalian cell membrane [6, 8]. 
Here we used the single cysteine mutations of the IIb and 3 TM region (IIb residues 965-995 
and 3 residues 691-723, Fig. 3.1) and applied the similar method to determine if the IIb or 3 
TM domain forms homooligomers during integrin signaling. As suggested by TOXCAT assay 
[15, 16] and predicted by computer modeling [17-19], the IIb TM helix forms homodimers, and 
the 3 TM helix forms homotrimers, with similar residues (for example GXXXG motif in the 
IIb subunit) in their interface as observed in the heterodimeric interface. If this homomeric 
interface is actually formed in the mammalian cell membrane, we expected that some single 
cysteine mutations of these residues would form homodimeric disulfide bonds in the presence of 
an oxidation catalyst such as Cu-phenanthroline. In addition, 2-BP was used to block cysteine 
palmitoylation, which can inhibit disulfide formation; saponin was used to increase the 
permeability of Cu-phenanthroline and the efficiency of disulfide bond formation as described 
previously [8]. To confirm the efficiency of disulfide bond formation in the presence of Cu-
phenanthroline, several cysteine pairs (one from α and the other from β) at the TM or TM 
proximal region, which have been shown to form heterodimeric disulfide bonds [6, 8], were used 
as control.  
 
Fig. 3.1 Sequences of the IIb and 3 TM regions. Segments predicted as TM are boxed. Residues 
used for cysteine scanning in this study are indicated by heavy dots. 
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As shown in Figure 3.2, the cysteine pair 971C/697C formed a heterodimeric disulfide 
bond in the presence of Cu-phenanthroline, as described previously [6]. By contrast, none of the 
single cysteine mutants of IIb TM regions formed homomeric disulfide bonds under these 
conditions except for IIb W967C (Fig. 3.2). As reported previously [6, 7], IIb W967C, when 
cotransfected with wild-type β3, formed a homomeric disulfide bond in the resting state, and 
therefore, the IIbβ3 integrin associated to form a disulfide-bridged tetramer (IIbW967C/β3)2. 
This residue is located outward, away from the heterodimeric interface or predicted homodimeric 
interface [6, 7]. When DTT was added, the disulfide bond was reduced. After DTT was removed 
and Cu-phenanthroline was added to catalyze disulfide formation, only trace amount of 
homomeric disulfide was formed on the cell surface (Fig. 3.3A). We further traced the disulfide-
bond formation of IIb W967C mutant after 35S labeling by lysing cells and 
immunoprecipitating the protein at different time points (Fig. 3.3B). After 30 minutes of 
labeling, IIb precursor was formed. Then after 1 hour, mature IIb subunit was formed and 
trace amount of disulfide-bonded IIb was observed. In 1.5 hours, a significant amount of 
disulfide-bonded IIb was formed. This suggests that the homomeric disulfide bond is formed 
during biosynthesis and post-translational modification. Since this disulfide bond of the IIb 
mutant is formed during biosynthesis and in the resting state in which heterodimeric TM 
association is not affected, we excluded this mutant for the following studies. Except for this 
cysteine mutant, none of the other 30 IIb cysteine mutants formed a homomeric disulfide bond 
(Fig. 3.2), neither did any of the 34 β3 cysteine mutants (Fig. 3.4). These results suggest that the 
IIb and β3 TM helices do not form homomeric association when IIbβ3 is in the resting state.  
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Figure 3.2 Integrin IIb TM domains do not form homooligomers before and after soluble ligand 
binding.  Except for IIbW967C, none of the cysteine mutants of the IIb TM regions formed 
homomeric disulfide bonds before or after soluble ligand binding. 
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Figure 3.3 The homomeric disulfide bond of the IIbW967C was formed during biosynthesis.  A. 
Formation of the homomeric disulfide bond after DTT treatment. The 
35
S-labeled cells were treated with 
or without 2 mM DTT at 37
o
C for 10 min. After washing with TBS, DTT treated cells were incubated 
with or without Cu-Phenanthroline. B. Tracing the formation of disulfide bond of IIb W967C mutant 
after labeling. The cells were lysed at different period of time after 
35
S-labeling and integrin IIb3 was 
immunoprecipitated and subjected to 7.5% non-reducing SDS-PAGE.  
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Figure 3.4  Integrin 3 TM domains do not form homooligomers before and after soluble ligand 
binding.  None of the cysteine mutants of the 3 TM regions formed homomeric disulfide bonds before 
or after soluble ligand binding.  
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To determine if the  and β TM domains form homooligomers after soluble ligand 
binding, we used Mn
2+
 to activate integrin IIbβ3 followed by binding of soluble fibrinogen and 
ligand-mimetic RGD peptide. It has been shown that ligand binding induces integrin 
conformational changes that expose the LIBS (for Ligand-Induced Binding Site) epitopes, which 
are located at the interfaces between the headpiece and tailpiece and between the  leg and β leg 
so that they are buried in the bent conformation but exposed in the extended conformation [26, 
27]. We used anti-3 LIBS mAb LIBS1 [28] to determine the conformational states of the 
αIIbβ3 in the presence of Mn2+ with fibrinogen or RGD. The LIBS1 bound poorly to wild type 
IIbβ3 in Ca2+ (Fig. 3.5), suggesting that it is in the bent conformation.  The binding 
significantly increased when fibrinogen with Mn
2+
 or RGD with Mn
2+
 were added (Fig. 3.5), 
suggesting that these ligands bound to integrins, and they stabilized integrins in the more 
extended conformation.  Disulfide scanning was used to test whether  and β TM domains form 
homomeric interface after integrin bound to soluble fibrinogen and RGD peptide under the same 
condition, and no homomeric disulfide formation was observe for any mutants except the 
W967C as described above (Fig. 3.2, 3.3, 3.4), suggesting that after ligand binding, even 
though integrins are stabilized in the more extended state and probably with two separating legs 
and TM/cytoplasmic tails, homooligomerization does not occur for TM/cytoplasmic tails in 
mammalian cell membrane. 
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Fig. 3.5 Exposure of the LIBS1 eptitope. LIBS epitope exposure was determined as the percentage of 
MFI of anti-LIBS1 antibody relative to non-functional anti-3 mAb AP3.  Error bars are standard 
deviation (SD). 
 
Integrin TM Domains Do Not Form Homooligomers During Inside-out Signaling 
Upon the stimulation of external agents such as thrombin and ADP, the intracellular 
molecules (talin, kindlin etc.) can bind to the cytoplasmic domain of integrins, disrupting the 
association of cytoplasmic domains and further triggering a cascade of inside-out signaling 
events [29, 30]. Previously we have shown that dissociation of the TM heterodimers is critical 
for integrin activation [6]. In addition to the TM heterodimeric association and dissociation, the 
TM homomeric association was proposed to play an important role in this process [20, 21]. Here, 
we designed experiments to test whether integrin TM region form homooligomers during inside-
out activation. It is well known that the GFFKR motif in the IIb cytoplasmic domain is  crucial 
for maintaining integrin in the resting state. When the two phenylalanines of the GFFKR motif 
are mutated to alanines (GAAKR mutant), integrins are activated to bind ligands with high 
affinity. Thus, this GAAKR mutant can be used to mimic integrin inside-out activation [6]. We 
confirmed that the mutant bound fibrinogen constitutively; in addition, it bound LIBS1 much 
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better than the wild type in Ca
2+
 condition (Fig. 3.5), indicating that the mutation shifts integrin 
towards more extended conformation, well mimicking inside-out signaling. We made 6 single 
cysteine mutants using this GAAKR construct, and co-transfected with the wild-type β3 integrin. 
None of the IIb integrin cysteine mutants formed a homomeric disulfide bond (Fig. 3.6A).  
Similar results were obtained when 34 β3 single cysteine mutants were co-transfected with the 
IIb GAAKR mutant; none of these mutants formed a homomeric disulfide bond (Fig. 3.6B). 
These results strongly suggest that during integrin inside-out activation across the mammalian 
cell membrane, TM homomeric association is not formed. Therefore, the TM 
homooligomerization does not play any role in this process. 
 
 
Figure 3.6  Integrin TM domains do not form homooligomers during inside-out activation.  A. 
Cysteine mutations of the IIb GAAKR mutant were co-transfected with wild type 3 integrin. No 
homomeric disulfide bond was formed for any of the IIb cysteine mutants.  B. Cysteine mutations of the 
3 TM region were co-transfected with the IIb GAAKR mutant. No homomeric disulfide bond was 
formed for any of the 3 cysteine mutants. 
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Integrin TM Domains Do Not Form Homooligomers After Adhering to Immobilized 
Fibrinogen 
 
After binding to immobilized ligands, integrins on the mammalian cell surface will 
transmit outside-in signaling. We carried out a series of experiments to address whether TM 
homomeric association is formed during this process. We randomly chose two αIIb and two β3 
cysteine mutants and used them for cell adhesion and cell spreading assay. HEK293T cells 
transiently transfected with wild-type and mutant αIIbβ3 were seeded on fibrinogen-precoated 
dish surfaces at 37°C for 1 h.  The amount of adherent cells was assessed by quantifying the 
cellular lactate dehydrogenase (LDH) activity. All selected mutants could adhere to the 
immobilized fibrinogen similarly to the wild-type receptor, whereas the disulfide bounded 
mutant (α968C/β693C) showed much less adhesion, and DTT treatment which was used to 
disrupt the disulfide bond was able to recover its adhesion to the similar level to the wild-type 
with DTT (Fig. 3.7A). To test if the single cysteine mutations could affect cell spreading, 
HEK293T transient transfectants were coated on the immobilized fibrinogen at 37°C for 1 h, 
followed by fixation and microscopic analysis. Cells transfected with all single cysteine mutants 
demonstrated cell spreading to the similar level to those transfected with the wild-type receptor. 
By contrast, the disulfide bounded mutant (α968C/β693C) showed no spreading, and DTT 
treatment restored cell spreading (Fig. 3.7B-C). These results confirmed that dissociation of the 
TM heterodimers is required for integrin outside-in signaling as described previously using CHO 
cell transfectants [25]. It also showed that the single cystein mutations in this region do not affect 
the integrin adhesion to immobilized fibrinogen, nor do they affect outside-in signaling.  
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Figure 3.7  Cell adhesion and spreading of randomly selected TM cysteine mutants. A.  Adhesion of 
HEK293T transfectants in the presence of 1mM Ca
2+
 to surfaces coated with 20 µg/ml fibrinogen.  The 
amount of bound cells was determined by measuring LDH activity as described in Materials and 
Methods.  Data are representative of three independent experiments, each in triplicate.  B.  DIC images of 
HEK293T transfectants after adhering to immobilized fibrinogen at 37°C.  The images are representatives 
of three independent experiments.  Scale bar represents 10 µm.  C.  Quantification of the areas of 
adhering/spreading cells as described in Materials and Methods.  Error bars are SD.  *** P <0.001.  
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It is widely believed that lateral association (i.e. “clustering”) of integrin heterodimers, 
which occurs as a consequence of multivalent ligand binding [31, 32], plays a major role in 
outside-in signaling (see review [33]). It was also shown that ligand binding can directly lead to 
and stabilize separation of integrin cytoplasmic domains [34], and this integrin conformational 
change is critical for outside-in signaling as well [25]. However, it remains unclear whether the 
integrin TM homomeric interaction after the TM helix separation is critical for integrin 
clustering. To assess formation of integrin clustering, HEK293T transfectants were allowed to 
adhere to fibrinogen-coated substrates followed by fixation and staining with fluorescent anti-
IIb3 antibodies.  Under these conditions, wild-type integrins and all cysteine mutants could be 
readily detected in clustered patterns (Fig. 3.8). Interestingly, although disulfide bounded mutant 
is defected with cell spreading, it formed the similar cell clustering as others, in contrast to the 
negative control in which cytochalasin-D was used to disrupt the actin polymerization linked 
integrin clustering (Figs. 3.7-3.8).   
We then further determined, under the same condition, whether the integrin TM domains 
formed homooligomers in the plasma membrane. HEK293T cells transfected with a variety of 
IIb and β3 cysteine mutants were seeded on pre-coated fibrinogen surface at 37oC for 1 hr. 
After cells fully adhered and spread on immobilized fibrinogen, Cu-phenanthroline was added to 
catalyze disulfide bond formation. Four cysteine mutation pairs, 968C/693C, 971C/697C, 
972C/697C and 955C/723C, were used as control to confirm the efficiency of oxidation. 
Under this condition, four cysteine pairs formed disulfides efficiently.  By contrast, none of the 
IIb or 3 TM cysteine mutations formed a homomeric disulfide bond (Figs. 3.9). Since these 
integrins adhered to the immobilized fibrinogen, clustered on the cell surface and transmitted 
outside-in signaling leading to cell spreading, the results suggest that homomeric association of 
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the integrin TM domains is not important for integrin functions. Similar results were obtained 
when CHO cells were used (data not shown), suggesting that integrin TM/cytoplasmic domains 
do not form homomeric interaction during integrin outside-in signaling in mammalian cells. 
 
 
Figure 3.8 Integrin clustering of selected TM cysteine mutants. Confocal microscopy studies of 
integrin clustering on the cell surface. Cells expressing IIb3 wild type and mutants were seeded on 
fibrinogen-coated surface for 1h at 37°C in the presence or absence of cytochalasin-D (Cyto D).  Attached 
cells were then stained with anti-β3 mAb AP3 in the presence or absence of Cyto D for 30 minutes at 
room temperature, followed by staining with FITC-conjugated goat anti-mouse IgG for 30 minutes at 
room temperature. After fixation, cells were subjected to confocal microscopy. 
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Figure 3.9  Integrin TM domains do not form homooligomers after cell adhering to the immobilized 
fibrinogen. A. None of the IIb cysteine mutants formed homomeric disulfide bond after adhering to the 
immobilized fibrinogen. B. None of the 3 cysteine mutants formed homomeric disulfide bond after 
adhering to the immobilized fibrinogen. 
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Discussion 
It has been shown that TM heterodimeric association stabilizes integrins in the resting 
state; when integrins are activated by intracellular signals, two TM/cytoplasmic tails separate, 
leading to conformational change of the ligand-binding extracellular regions, resulting in high 
affinity for ligands [6-8, 12, 35, 36-39]. Therefore, equilibrium between the dissociated 
monomers and associated heterodimers of the TM domains is critical for integrin inside-out 
activation. Based on the observation that integrin TM helices formed homooligomers using 
recombinant peptides in detergent [14, 20, 22], the GALLEX assay in bacteria [39], the 
TOXCAT assay in bacteria [15, 16] and the computational modeling [17-19], TM homomeric 
association has been suggested to be important for integrin activation [20-22]. Mutagenesis 
studies on the proposed TM homomeric interface residues showed that these mutations could 
lead to integrin activation, suggesting that heterodimer dissociation is sufficient to activate 
integrins [21]. Therefore, a push-pull model was proposed in which after dissociation of the TM 
heterodimer,  integrins are stabilized by TM homomeric association [21].  
Here our experiments on mammalian cell transfectants using full-length integrin IIb3 
showed that the IIb and 3 TM domains do not form any homomeric association in the resting 
state, nor do they form after soluble ligand binding. The only mutant that formed a homomeric 
disulfide is IIb_W967C, as reported previously [6, 7]. We found that this homomeric disulfide 
was formed during biosynthesis and in the integrin resting state, and dissociation of the TM 
heterodimer is not required for its formation. Therefore, we do not think that the same 
homomeric association occurs during integrin inside-out activation or outside-in signaling. We 
found that except for this mutant, none of the other 30 IIb and 34 3 cysteine mutants formed a 
homomeric disulfide bond before or after binding to soluble ligands. In addition, during integrin 
inside-out activation, the integrin TM domains do not form any homomeric association that can 
be detected by disulfide scanning. Integrins must be regulated to be activated and de-activated 
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quickly in mammalian cells, even within seconds. It has been shown that detachment of integrin 
from ligands in the trailing edge is critical for integrin functions [40], and mutations that 
constitutively active integrins result in malfunctions [41-44]. Therefore, it is unlikely that 
integrin TM domains form more stable homomeric association during inside-out signaling. 
Although integrin clustering is known to participate in integrin signaling pathways [45- 
48], the exact mechanisms of integrin clustering remain elusive. One mechanism proposes that 
the integrin TM homooligomerization promotes integrin clustering [20]. Studies have established 
that extracellular ligand binding triggers integrin conformational changes that promote oligomer 
assembly through TM fragments [49-51]. In this study, we observed that after adhering to 
immobilized fibrinogen integrins clustered on the cell surface, but we did not detect any integrin 
TM homomeric interaction under this condition. Interestingly, the heterodimeric disulfide-
bonded integrin formed clusters, suggesting that even the dissociation of integrin / TM 
domains is not required for integrin clustering. Therefore, our study suggests that integrin 
clustering is induced by bringing several integrins physically close together by multimeric 
ligands, and the TM homomeric association is not required for this process.  
Even though the TM separation is not required for integrin clustering, it is critical for 
integrin outside-in signaling [25]. We showed that all cysteine mutants could adhere and spread 
on the fibrinogen-coated surface, suggesting that they could transmit signals into the cells after 
binding to immobilized ligands. However, we did not observe any TM homomeric disulfide 
formation in the same condition, indicating that the TM homomeric association does not occur 
during integrin outside-in signaling. The reason why integrin outside-in signaling requires the 
TM separation but not homomeric association is unknown. Based on the previous FRET studies 
[34], we assume that ligand-induced TM separation is likely coupled to cytoplasmic domain 
separation, implying that - cytoplasmic domain interactions somehow constrain or inhibit 
kinase activation  [7, 25, 29, 34, 52]. One possibility is that separation of TM and cytoplasmic 
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domains induced by multimeric ligand binding is required for kinases or other intracellular 
proteins to bind integrin cytoplasmic tails. On the other hand, some studies have shown that 
certain tyrosine kinases, such as Src, associate constitutively with integrin IIb3 in platelets, 
and platelet adhesion to fibrinogen causes a rapid increase in Src activation [53].  Thus, another 
possibility is that the association of the integrin TM and cytoplasmic domains somehow 
constrains the activity of integrin tail-bound kinases, whereas dissociation of the TM and 
cytoplasmic domains releases these constraints.  In either case, binding of multimeric ligands 
brings integrins together, and at the same time, induces dissociation of the TM/cytoplasmic 
domains, resulting in kinase auto-phosphorylation and activation. The current study strongly 
suggests that during this process, the TM homomeric association does not play any role in kinase 
activation. 
            In conclusion, our study shows that the integrin TM homomeric association does not 
occur in mammalian cell membranes before or after soluble ligand binding, during inside-out 
activation or outside-in signaling. Therefore, conformational change induced by intracellular 
signals or extracellular ligands, more specifically, separation of TM and cytoplasmic domains, 
but not the homomeric association is critical for integrin bidirectional signaling.  
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       Integrin signaling is often accompanied by its conformational rearrangement. Understanding 
the biologically relevant conformational changes is important to unravel the mechanisms of 
integrin signaling, and to further provide effective cues for drug design for integrin-involved 
diseases. Although significant progress has been made in integrin structural studies and its 
conformational changes in the past decade, many aspects, especially the conformational 
alteration coupled with bidirectional signaling, need to be further investigated in more details. 
        To address the roles of integrin lower leg in integrin signaling, we have introduced a 
disulfide bond and two glycosylation sites into the interface between the α-subunit Calf-2 
domain and β-subunit I-EGF4 domain to either clasp or disrupt the association of this region. 
Then we determined the effect of these mutants on ligand binding and outside-in signaling. In 
addition, conformational states and cell adhesion were also tested (Chapter 2). Our results 
showed that restricting the association by disulfide bond abolished the inside-out activation and 
outside-in signaling, whereras disrupting the interface by glycosylation mutations activates the 
integrins by a global conformational change. Therefore, separation of integrin lower leg is 
required for inside-out activation and outside-in signaling.  
       In chapter 3, we used cysteine scanning mutagenesis method to test the possibility of 
homomeric interaction under the context of the full length integrin in mammalian cells under 
physiological and activating conditions. Our results showed that TM domains do not form 
homooligomers in the mammalian cell membrane, which is in contrast with previous data 
obtained in micelles and bacterial membranes in which the homooligomers were observed using 
TM fragments.  Further studies showed that disulfide-bonded integrin heterodimer is able to 
aggregate to form clusters, even though its bidirectional signaling is blocked. It is generally 
believed that integrin outside-in signaling is controlled by conformational change and clustering. 
Our results show that integrin TM homomeric association does not play any role in integrin 
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clustering. Furthermore, the integrin TM domains do not form homooligomers after adhering to 
immobilized ligands. Taken together, the homooligomerization through TM helices is not 
important for αIIbβ3 inside-out activation and outside-in signaling. We think that binding of 
multimeric ligands brings integrins physically close to each other, leading to clustering; at the 
same time, ligand binding triggers integrin leg separation, resulting in kinase activation.           
        For extracellular domains, two models have been proposed to address the possible 
conformational changes upon inside-out activation: The “switchblade” model posits the full 
extension is necessary for ligand binding, whereas in the “deadbolt” model, the extension is the 
post-ligand binding event. Both models have received various supports. Studies have established 
that integrins can exist in several states: low, intermediate, and high affinity states. The 
coexistence of the two conflicting models may suggest that some intermediate conformations 
could be enough to fulfill the mission of ligand binding at least in some signaling occasions. 
Additional characterization of the biologically relevant conformational change is needed to fully 
understand the story.  
         Currently, we are designing the experiments to examine these two models using FRET. A 
FITC or Alexa Fluor®488 labeled antibody that binds to integrin headpiece and a dye that labels 
the plasma membrane will be used as a donor-acceptor pair to determine the distance between 
integrin headpiece and the plasma membrane using wild type and various mutant integrins under 
physiological and activating conditions. Since this distance reflects the extent of integrin 
extension, with different constructs under various conditions, we will be able to determine the 
dynamics of conformational change in different scenarios. The FRET will also be used under  the 
conditions of inside-out activation, in which the talin head domain will be co-transfected with the 
integrins, or the external activators such as ADP and thrombin will be added to induce the 
platelet activation. No change of FRET signal upon addition of the activators would support the 
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deadbolt model; while a loss of FRET signal would be consistent with the switchblade model; a 
FRET signal change in between would lead us to propose a new model. 
         As far as the TM and cytoplasmic domains are concerned, although it is known that the 
separation of TM is required for integrin signaling, the detailed mechanism needs to be further 
investigated. Studies have shown that separation of the two associated subunits is caused by 
either talin binding to two positions of integrin cytoplasmic fragments in succession or by talin 
binding to cytoplasmic domain and inner membrane respectively. However, it was also proposed 
that the lateral force caused by actin polymerization results in TM separation. Interestingly, it 
was found that β TM fragment is tilted in the membrane bilayer in the active state. The tilting of 
β TM domain may play an important role in the activation. More research is needed to define this 
phenomenon. In addition, β cytoplasmic domains were considered as the scaffold for integrin 
signaling, since a variety of intracellular proteins are directly or indirectly involved in connection 
with this region. Much work remains to be done to uncover the intracellular signaling events.     
         In conclusion, our work presented in this dissertation has shed new light on the mechanism 
of how integrins transmit signals bidirectionally across the plasma transmembrane. However, 
many signaling events coupled with conformational rearrangement remain unclear. Future 
investigation is necessary to advance our understanding of integrin signaling.   
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